rs3848724
Variant summary
Our verdict is Benign. Variant got -19 ACMG points: 0P and 19B. BP4_ModerateBP6_Very_StrongBP7BA1
The NM_020708.5(SLC12A5):c.355C>A(p.Arg119=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0276 in 1,614,082 control chromosomes in the GnomAD database, including 1,189 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Synonymous variant affecting the same amino acid position (i.e. R119R) has been classified as Benign.
Frequency
Consequence
NM_020708.5 synonymous
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -19 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
SLC12A5 | NM_020708.5 | c.355C>A | p.Arg119= | synonymous_variant | 4/26 | ENST00000243964.7 | |
SLC12A5 | NM_001134771.2 | c.424C>A | p.Arg142= | synonymous_variant | 4/26 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
SLC12A5 | ENST00000243964.7 | c.355C>A | p.Arg119= | synonymous_variant | 4/26 | 1 | NM_020708.5 | A1 |
Frequencies
GnomAD3 genomes AF: 0.0291 AC: 4428AN: 152238Hom.: 170 Cov.: 32
GnomAD3 exomes AF: 0.0414 AC: 10390AN: 251198Hom.: 531 AF XY: 0.0373 AC XY: 5065AN XY: 135806
GnomAD4 exome AF: 0.0275 AC: 40179AN: 1461728Hom.: 1016 Cov.: 32 AF XY: 0.0272 AC XY: 19774AN XY: 727182
GnomAD4 genome AF: 0.0291 AC: 4433AN: 152354Hom.: 173 Cov.: 32 AF XY: 0.0309 AC XY: 2301AN XY: 74510
ClinVar
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | GeneDx | Nov 12, 2018 | - - |
not specified Benign:1
Benign, criteria provided, single submitter | clinical testing | Unidad de Genómica Garrahan, Hospital de Pediatría Garrahan | Jul 15, 2024 | This variant is classified as Benign based on local population frequency. This variant was detected in 23% of patients studied in a panel designed for Epileptic and Developmental Encephalopathy and Progressive Myoclonus Epilepsy. Number of patients: 21. Only high quality variants are reported. - |
Developmental and epileptic encephalopathy, 34 Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Feb 01, 2024 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at